Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer-Reference-Cited by-同舟云学术

Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer

Published:2009-08 Issue: Volume:18 Page:S1-S11
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Chlebowski Rowan,Cuzick Jack,Amakye Dereck,Bauerfeind Ingo,Buzdar Aman,Chia Stephen,Cutuli Bruno,Linforth Rick,Maass Nicolaì,Noguchi Shinzaburo,Robidoux André,Verma Sunil,Hadji Peyman

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference92 articles.

1. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;The ATAC Trialists' Group;Lancet Oncol,2008

2. BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer;Mouridsen;Cancer Res,2009

3. Surviving recurrence: psychological and quality-of-life recovery;Yang;Cancer,2008

4. Quality of life of women with recurrent breast cancer and their family members;Northouse;J Clin Oncol,2002

5. Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life;Sarenmalm;J Pain Symptom Manage,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adapting and implementing breast cancer follow-up in primary care: protocol for a mixed methods hybrid type 1 effectiveness-implementation cluster randomized study;BMC Primary Care;2023-11-09

2. New steps on an old path: Novel estrogen receptor inhibitors in breast cancer;Critical Reviews in Oncology/Hematology;2022-12

3. Menopausal Hormone Therapy and Breast Cancer;The Cancer Journal;2022-05

4. Aromatase Inhibitors: Development and Current Perspectives;Indian Journal of Pharmaceutical Education and Research;2022-03-16

5. Influence of Estrogen Treatment on ESR1+ and ESR1− Cells in ER+ Breast Cancer: Insights from Single-Cell Analysis of Patient-Derived Xenograft Models;Cancers;2021-12-19